Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
Dr. Michele Brignole ,
With vasovagal susceptibility probably present in all healthy humans, isolated VVS is a physiological phenomenom. This event occurs in patients whose autonomic regulation outside the episodes of syncope is normal. Vasovagal disease, on the other hand, begins in the advanced age of diseased patients. In vasovagal disease, outside the episodes of syncope autonomic regulation is usually not normal.
Isolated vasovagal syncope (VVS) is not a disease, but rather, the clinical manifestation of an autonomic reflex predisposed in all (or almost all) individuals. Why certain subjects appear to be more susceptible than others to the development of paradoxical hypotension and bradycardia, and why the event occurs at one time and not another, remains largely unknown. Isolated VVS should be distinguished from vasovagal disease, in which VVS appears as an expression of a pathological process, mainly related to a generalised involvement of the autonomic nervous system. Learning to differentiate these two forms has important therapeutical consequences.
Classical vasovagal syncope (VVS) is mediated by emotional or orthostatic stress and can be diagnosed by history taking (1). It is diagnosed when precipitating events such as fear, severe pain, emotional distress, instrumentation or prolonged standing are associated with typical prodromal symptoms (1). Classical VVS generally starts at a young age yet natural histories are extremely various; certain subjects experience only a single episode over the course of their lives, while others have frequent episodes. In the vast majority of subjects, classical VVS is not associated with cardiovascular, neurological or other diseases, and therefore classical VVS constitutes an isolated manifestation (“Isolated VVS”). Vasovagal syncope is benign and very frequent; although estimates are difficult to make, it is likely that up to 50% of all individuals experience a loss of consciousness at some time during their lives. Most of these have only one or a few episodes (2).
1) Vasovagal susceptibility is probably present in all healthy humans.
Even if the clinical manifestation, i.e., syncope, occurs in about half of individuals in their lives, a vasovagal susceptibility is probably present in all healthy humans since their youth. This assertion is supported by several data (2): • Head-up tilt testing is used to assess individual susceptibility to VVS. Nevertheless, up to 50% of asymptomatic healthy subjects show a positive response to head-up tilt testing when strong stressors are used. Positivity is particularly high in healthy asymptomatic children. Adding this percentage to that of syncopal patients, a vasovagal susceptibility can be evidenced in about 75% of the general population. • Hemorrhagic shock can trigger a situation similar to VVS. The volume loss caused by hemorrhage results in hypotension and a fall in venous return, which can lead to inappropriate sympathico-inhibition and a subsequent paradoxical response characterised by a further fall in blood pressure, associated with bradycardia. This vasovagal reaction, which is probably secondary to a strong trigger, such as a severe reduction in venous return, can be observed in subjects with no history of syncope. • Astronauts are selected on the basis of their great resistance to orthostatic and gravitational changes. Despite this selection, about 20% experience presyncope, and some experience a frank bradycardic syncope during upright posture on the day of landing after a short-duration space flight. This has been attributed to central remodeling, which is a transient dysfunction of central integration of baroreflex afferent input due to the fact that during weightlessness the central nervous system receives no baroceptor input to counter upright posture. An autonomic reflex which is potentially triggered in the vast majority of individuals cannot be regarded as a pathological disorder.
2) Blood pressure regulation outside the episodes of syncope is normal.
Isolated VVS subjects are generally normotensive and have normal blood pressure regulation outside the episodes of syncope (2). In general, the behavior of blood pressure during the first minutes of head-up tilt test before the beginning of vasovagal reaction is similar in VVS subjects and in control subjects without a history of fainting. Contrary to general belief, subjects with VVS do not have an increased vagal tone during everyday life, suggesting that a generalised state of autonomic involvement is not present in these individuals. Many hormonal factors, such as serotonine, adrenaline, arginine vasopressin, ß-endorphins, adenosine and galanin have been supposed to have a role in eliciting VVS. However, a causal role of these hormonal factors – and an abnormality of hormonal function - has never been definitely demonstrated. To conclude, Isolated VVS seems to be not a disease, but rather the clinical manifestation of an autonomic reflex predisposed in all (or almost all) individuals. Why certain subjects appear to be more susceptible than others to the development of paradoxical hypotension and bradycardia, and why the event occurs at one time and not at another, remains unknown.
The classification of the causes of syncope used by the Task Force on syncope of the European Society of Cardiology includes some forms of non-classical VVS which are diagnosed on the basis of minor clinical criteria, exclusion of other causes of syncope (absence of heart disease) and positive response to head-up tilt test (1). Examples of non-classical VVS include episodes without (or with minimal) triggering events or prodromal symptoms.
1) Vasovagal symptoms begin in advanced age in diseased patients.
It is known that clinical manifestations of VVS change significantly in older subjects and that medical history has a limited value in establishing the cause of syncope in older people (3).
In the EGSYS 2 study (4) the age of onset of VVS in 190 subjects admitted urgently to hospital was 52±23 years (2). This study involved a population-based sample of consecutive patients referred to the emergency department, a sample which was biased only by access criteria. Their age distribution showed that the age of onset is distributed throughout life, peaking at the age of 20 and after the age of 70 years (figure 1).
In subjects in whom VVS starts in old age, loss of consciousness cannot be regarded as an isolated manifestation, as it is frequently associated not only to cardiovascular or neurological diseases, but also to other dysautonomic disturbances, such as carotid sinus hypersensitivity, post-prandial hypotension, progressive orthostatic hypotension and symptoms of autonomic dysfunction (abnormal sweating, abnormal thermoregolation etc.) (5,6). Even though VVS starting in old age shares the same pathophysiological mechanism of hypotension – bradycardia with isolated VVS both during head-up tilt test and during documented spontaneous syncope, these findings should be regarded as an expression of a pathological process mainly related to a generalised involvement of the autonomic nervous system or, more in general, to aging processes. Vasovagal disease starting in old age progressively worsens over time, and major injuries are frequent (7), mainly when prodromes are lacking. In this regard, a specific therapy is often needed. 2) Blood pressure regulation outside the episodes of syncope is frequently abnormal. Apart from the frequent association with hypertension, a progressive orthostatic hypotension is commonly seen in these patients because of age-related impairment in baroreflex mediated vasoconstriction and chronotropic responses of the heart, as well as to the deterioration of the diastolic filling of the heart (8). The cerebral hypoperfusion caused by hypotension leads to an inability to tolerate the standing position and causes important impairment of the quality of life mainly because of dizziness, presyncope, weakness and palpitations.
The clinical features of isolated VVS and of vasovagal disease are summarized in table 1. Although this subdivision engenders the risk of over-simplification since several intermediate forms are present, it may be useful for practical purposes nevertheless.
Table 1. Schematic differences in clinical features of isolated vasovagal syncope and vasovagal disease.Isolated vasovagal syncope :
Patients who seek medical advice after having experienced an isolated (classical) VVS require reassurance and education regarding the nature of the disease and the avoidance of triggering events. In general, education and reassurance are sufficient for most patients and no specific therapy is generally warranted in most subjects. Non-pharmacological “physical” treatments are emerging as a new front line treatment of vasovagal syncope. In highly motivated patients with recurrent vasovagal symptoms, the prescription of progressively prolonged periods of enforced upright posture (so-called ‘tilt-training’) may reduce syncope recurrence. However, this treatment is hampered by the low compliance of the patients in continuing the training programme for a long period (9). Some recent clinical trials (10,11,12) have shown that isometric counterpressure manoeuvres of the legs (leg crossing), or of the arms (hand grip and arm tensing), are able to induce a significant blood pressure increase during the phase of impending vasovagal syncope, which allow the patient to avoid or delay losing consciousness in most cases. On the other hand, in patients affected by vasovagal disease, modification or discontinuation of hypotensive drug treatment for concomitant conditions and avoidance of triggering situations are often the first line measures for the prevention of syncope recurrences. Treatment is not necessary for patients who have sustained a single syncope and are not having syncope in a high risk setting. Additional treatment may be necessary in high risk or high frequency settings when syncope is very frequent, e.g. alters the quality of life, or syncope is recurrent and unpredictable (absence of premonitory symptoms) and exposes patients to the “high risk” of trauma. In these latter situations, a careful investigation of the relative importance of cardioinhibitory and vasodpressor components of the reflex is mandatory before embarking in specific treatment. Lower limb compression bandaging is effective in avoiding orthostatic systolic blood fall and reducing symptoms in elderly patients affected by progressive orthostatic hypotension. Home treatment based on self administered elastic leg stockings seems feasible, safe and well accepted by most patients (8). Cardiac pacing appears to be beneficial in VVS patients who have also carotid sinus hypersensitivity and, although only one relatively small randomized controlled trial has been undertaken, pacing is acknowledged to be the treatment of choice when bradycardia has been documented (1). The role of cardiac pacing for vasovagal disease in the absence of carotid sinus hypersensitivity is not yet established. It seems that pacing therapy might be effective in certain, but not in all patients. This is not surprising if we consider that pacing is probably efficacious for asystolic reflex but has no role in combating hypotension which is frequently the dominant reflex in neurally-mediated syncope. A recent study using the implantable loop recorder as reference standard (7) showed that only about half of the patients had an asystolic pause recorded at the time of spontaneous syncope. A new strategy of treatment with cardiac pacing delayed until proper documentation of the mechanism of syncope is established- limited to those patients who had asystole at the time of syncope- proved to be very effective It reduced syncopal recurrence rate by 90% to an absolute value of 5% at 1 year (7).
The content of this article reflects the personal opinion of the author/s and is not necessarily the official position of the European Society of Cardiology.
1. Brignole M, Alboni P, Benditt DG et al. Guidelines on management (diagnosis and treatment) of syncope – Update 2004. Europace 2004;6:467–537 2. Alboni P, Brignole M, Degli Uberti E. Is vasovagal syncope a disease? Europace 2007 (in press) 3. Del Rosso A, Alboni P, Brignole M et al.. Relation of Clinical Presentation of Syncope to the Age of Patients. Am J Cardiol 2005;96:1431–1435 4. Brignole M, Menozzi C, Bartoletti A, et al. A new management of syncope. Prospective systematic guideline-based evaluation of patients referred urgently to general hospitals. Eur Heart J 2006; 27: 76-82 5. Brignole M, Menozzi C, Gianfranchi L, et al. Carotid sinus massage, eyeball compression and head-up tilt test in patients with syncope of uncertain origin and in healthy control subjects. Am Heart J 1991;122:1644–51 6. McIntosh SJ, Lawson J, Kenny RA. Clinical characteristics of vasodepressor, cardioinhibitory and mixed caortid sinus syndrome in the elderly. Am J Med 1993;95:203–8 7. Brignole M, Sutton R, Menozzi C et al. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. Eur Heart J 2006; 27, 1085–1092 8. Podoleanu C, Maggi R, Brignole M, et al. Lower limb and abdominal compression bandages prevent progressive orthostatic hypotension in the elderly. A randomized placebo-controlled study. J Am Coll Cardiol 2006; 48: 1425-32 9. Ector H, Reybrouck T, Heidbuchel H, et al. Tilt training: a new treatment for recurrent neurocardiogenic syncope or severe orthostatic intolerance. Pacing Clin Electrophysiol 1998; 21:193-196. 10. Brignole M, Croci F, Menozzi C, et al. Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope. J Am Coll Cardiol 2002; 40: 2054-2060 11. Krediet P, van Dijk N, Linzer M, et al. Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing. Circulation 2002; 106: 1684-1689 12. van Dijk N, Quartieri F, Blanc JJ, et al. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope. The Physical Counterpressure Manoeuvres Trial (PC-Trial). J Am Coll Cardiol 2006; 48:1652–7
Dr M. Brignole Lavagna, Italy Member of the Committee for Scientific Initiatives of EHRA
Our mission: To reduce the burden of cardiovascular disease.
© 2020 European Society of Cardiology. All rights reserved.